Turnaround

Biotechnology firm Equillium is executing a profound strategic overhaul, pivoting its entire operational focus to a single, promising drug candidate....

For Replimune and its investors, 2026 is shaping up to be a defining period. After a significant regulatory setback in...

The once high-flying restaurant chain Chipotle Mexican Grill is confronting significant headwinds. Following a disappointing earnings report and a reduction...

The athletic apparel landscape is undergoing a significant transformation, with former industry kingpin Nike facing substantial headwinds. As emerging competitors...

Kraft Heinz finds itself navigating turbulent waters as market confidence erodes following disappointing financial results and a downward revision of...

The Chinese electric vehicle giant BYD is navigating its most significant profit decline in four years, prompting a strategic pivot...

A dramatic shift in sentiment is underway among market experts covering Austrian steel producer Voestalpine. In a rapid succession of...

While Redcare Pharmacy shares continue their prolonged decline, having shed more than 60% from their December peak, a significant development...

After enduring a prolonged period of selling pressure, shares of Australian rare earths producer Lynas Rare Earths surged more than...

Australian counter-drone technology firm DroneShield is experiencing extreme volatility, with its shares rebounding sharply after a severe sell-off. The stock...